|
EML1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.819800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.092800E-01 |
| Normal-vs-Stage2 |
7.040200E-01 |
| Normal-vs-Stage3 |
7.455000E-01 |
| Normal-vs-Stage4 |
1.048790E-01 |
| Stage1-vs-Stage2 |
5.093200E-01 |
| Stage1-vs-Stage3 |
5.087800E-01 |
| Stage1-vs-Stage4 |
2.639000E-01 |
| Stage2-vs-Stage3 |
9.296800E-01 |
| Stage2-vs-Stage4 |
2.356000E-01 |
| Stage3-vs-Stage4 |
2.422200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.756600E-01 |
| Normal-vs-AfricanAmerican |
9.359800E-01 |
| Normal-vs-Asian |
4.027800E-02 |
| Caucasian-vs-AfricanAmerican |
8.393800E-01 |
| Caucasian-vs-Asian |
3.720800E-01 |
| AfricanAmerican-vs-Asian |
3.426000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.400000E-02 |
| Normal-vs-Female |
3.933900E-02 |
| Male-vs-Female |
1.578270E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.229800E-01 |
| Normal-vs-Extreme_Weight |
4.192800E-01 |
| Normal-vs-Obese |
4.828400E-01 |
| Normal-vs-Extreme_Obese |
6.817700E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.051000E-01 |
| Normal_Weight-vs-Obese |
4.157200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.140300E-02 |
| Extreme_Weight-vs-Obese |
2.180000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.993900E-02 |
| Obese-vs-Extreme_Obese |
3.296600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.264200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.651840E-01 |
| Normal-vs-Age(61-80Yrs) |
6.608400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.419890E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.048000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.174200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.030300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.756900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.434000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.756200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.665800E-01 |
| Normal-VS-Type2 PRCC |
2.911900E-02 |
| Normal-VS-KIRP CIMP |
4.357800E-01 |
| Normal-VS-Unclassified PRCC |
4.629200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.146150E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.283600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.783400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.369400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.177600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.604200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.310020E-02 |
| Normal-vs-N1 |
9.466600E-01 |
| Normal-vs-N2 |
1.475400E-01 |
| N0-vs-N1 |
2.684800E-01 |
| N0-vs-N2 |
9.363600E-01 |
| N1-vs-N2 |
6.096800E-01 |
|
|
